Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation
- PMID: 9539769
- PMCID: PMC22521
- DOI: 10.1073/pnas.95.8.4516
Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation
Abstract
Antigen presentation by major histocompatibility complex (MHC) class II molecules requires the participation of different proteases in the endocytic route to degrade endocytosed antigens as well as the MHC class II-associated invariant chain (Ii). Thus far, only the cysteine protease cathepsin (Cat) S appears essential for complete destruction of Ii. The enzymes involved in degradation of the antigens themselves remain to be identified. Degradation of antigens in vitro and experiments using protease inhibitors have suggested that Cat B and Cat D, two major aspartyl and cysteine proteases, respectively, are involved in antigen degradation. We have analyzed the antigen-presenting properties of cells derived from mice deficient in either Cat B or Cat D. Although the absence of these proteases provoked a modest shift in the efficiency of presentation of some antigenic determinants, the overall capacity of Cat B-/- or Cat D-/- antigen-presenting cells was unaffected. Degradation of Ii proceeded normally in Cat B-/- splenocytes, as it did in Cat D-/- cells. We conclude that neither Cat B nor Cat D are essential for MHC class II-mediated antigen presentation.
Figures
Similar articles
-
Proteases involved in MHC class II antigen presentation.Immunol Rev. 1999 Dec;172:109-20. doi: 10.1111/j.1600-065x.1999.tb01360.x. Immunol Rev. 1999. PMID: 10631941 Review.
-
Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.J Immunol. 2005 Jun 1;174(11):7066-74. doi: 10.4049/jimmunol.174.11.7066. J Immunol. 2005. PMID: 15905550
-
Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain.Immunol Lett. 1994 Dec;43(3):189-93. doi: 10.1016/0165-2478(94)90221-6. Immunol Lett. 1994. PMID: 7721331
-
Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing.Eur J Immunol. 2005 Dec;35(12):3442-51. doi: 10.1002/eji.200535320. Eur J Immunol. 2005. PMID: 16259009
-
The lysosomal cysteine proteases in MHC class II antigen presentation.Immunol Rev. 2005 Oct;207:229-41. doi: 10.1111/j.0105-2896.2005.00310.x. Immunol Rev. 2005. PMID: 16181340 Review.
Cited by
-
Lysosomal cysteine proteases: facts and opportunities.EMBO J. 2001 Sep 3;20(17):4629-33. doi: 10.1093/emboj/20.17.4629. EMBO J. 2001. PMID: 11532926 Free PMC article. Review.
-
Structure-guided development of selective TbcatB inhibitors.J Med Chem. 2009 Oct 22;52(20):6489-93. doi: 10.1021/jm900908p. J Med Chem. 2009. PMID: 19769357 Free PMC article.
-
Specific functions of lysosomal proteases in endocytic and autophagic pathways.Biochim Biophys Acta. 2012 Jan;1824(1):34-43. doi: 10.1016/j.bbapap.2011.07.003. Epub 2011 Jul 13. Biochim Biophys Acta. 2012. PMID: 21767668 Free PMC article. Review.
-
Cathepsin B Localizes in the Caveolae and Participates in the Proteolytic Cascade in Trabecular Meshwork Cells. Potential New Drug _target for the Treatment of Glaucoma.J Clin Med. 2020 Dec 28;10(1):78. doi: 10.3390/jcm10010078. J Clin Med. 2020. PMID: 33379277 Free PMC article.
-
Development of Purkinje cell degeneration in a knockin mouse model reveals lysosomal involvement in the pathogenesis of SCA6.Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17693-8. doi: 10.1073/pnas.1212786109. Epub 2012 Oct 10. Proc Natl Acad Sci U S A. 2012. PMID: 23054835 Free PMC article.
References
-
- Wolf P R, Ploegh H L. Annu Rev Cell Dev Biol. 1995;11:267–306. - PubMed
-
- Rudensky A Y, Preston-Hurlburt P, Hong S C, Barlow A, Janeway C A. Nature (London) 1991;353:622–627. - PubMed
-
- Gosh P, Amaya M, Mellins E, Wiley D C. Nature (London) 1995;378:457–462. - PubMed
-
- Germain R N, Rinkler A G. Nature (London) 1993;363:725–728. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous